chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I began completing and was timed out.  If anyone truly cares about my experience you can reach me at phone number or email.  This MUST stop!  My symptoms were identical to when my husband and I contracted what we believe was the Delta variant.  I pray someone cares enough to reach back out and hear our story.  God help us!!!!!!  We're being manipulated, intimidated, coerced and  mandated to do something I believe with have CATASTROPHIC consequences.  I beg you to be part of bringing light to this.  Please call or email any time for details!  I've have several experiences over the course of the last 2 years!!!
Patient reported lethargy, hives, flushing and pain at injection site starting in the evening of 1/15/2021. Symptoms continued 1/16 and 1/17/21. On 1/18/21 in the morning patient noted lymph node swelling in the groins and still continued with intermittent flushing. Dr. made aware on Monday morning. On 1/19/2021 patient reported no further lethargy, site pain, or flushing but lymph node swelling persisted in bilateral groins.
Pt describes immediately feeling muscle spasms upon receiving vaccine.  Pt also noted some tenderness to the area and a slight headache.  All of which the patient is still experiencing.
Within the first few min of getting the injection my throat got tight and my tongue swelled up and got numb. I could still breathe fine. Didn't need any additional help. Throat cleared up after a few hours. Tongue still numb and swollen a bit for around 4 days after. Each day got better but took a few days for it to return to normal. Still having some occasional numbness on day 5 but not swollen and only on the edge of tongue. At this reporting I seem to have mostly recovered. I had a video conference with my doctor a couple days after to discuss my reaction.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age. It was reported that at least three doses of VARIVAX (Merck) which was stored at temperatures outside of the current prescribed information might have been administered to patients on unspecified dates. No adverse events were reported. This is one of the several reports from the same reporter. Additional information has been requested.
RECEIVED LESS THAN 0.5ML OF VACCINE AS A BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 49-year-old white, not Hispanic or Latino male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient received covid-19 vaccine from unspecified manufacturer (form of admin, route of admin, batch number and expiry were not reported) dose was not reported, 1 in total, administered (dose number in series was 1) for prophylactic vaccination. It was unknown whether patient had any adverse events. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A expiry: 11-APR-2022), 0.3 ml, 1 in total, administered (dose number in series was 2) to left arm on 01-DEC-2021 for prophylactic vaccination which was an off label use as patient received less than 0.5ml of the Janssen covid-19 vaccine as a booster dose( vaccine uderdose). No concomitant medications were reported. As per the report, the HCP withdrew 8 doses of the Janssen Covid-19 vaccine from 5 vials and 7 doses from 1 vial which injected into 48 individuals. When the caller had a discussion with that HCP, mentioned that he/she injected 0.5mL but the caller mentioned that the math (she arrived at that by dividing 2.5mL by 5 doses) did prove that they received approximately around 0.3mL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the individual received less than 0.5ml of the Janssen covid-19 vaccine as a booster dose and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211210197, 20211209551, 20211210058, 20211209740, 20211209775, 20211209782, 20211209798, 20211209816, 20211209843, 20211209874, 20211209880, 20211210067, 20211210106, 20211210107, 20211210112, 20211210141, 20211210143, 20211210165, 20211210180, 20211210350, 20211210385, 20211210408, 20211210409, 20211210549, 20211210555, 20211210585, 20211210590, 20211210662, 20211210662, 20211210670, 20211210733, 20211210824, 20211212082, 20211212088, 20211210610, 20211210159, 20211210133, 20211209976, 20211209679, 20211209706, 20211209884, 20211209912, 20211209921, 20211210019, 20211210160 and 20211210334.
This is in follow-up to report(s) previously submitted on 7/16/2007. initial and follow-up information has been received from a physician and a registered nurse concerning a 17 year old female who on 15-MAY-2007 was vaccinated with a 0.5 ml first dose of Gardasil. On 15-MAY-2007 the patient experienced off and on headaches. The patient sought unspecified medical attention. On 17-MAY-2007, the patient recovered from off and on headaches. Additional information has been requested.
undiluted vaccine was given to pediatric patient. Caregiver reported no adverse effects on 7/21/22 on day of vaccination and again no adverse effects on 7/26/22
Fever, headaches, muscle aches, large red spot on injection arm, spot was hard, warm, painful, itchy.
10 minutes after vaccine, developed chest tightness with SOB. (has asthma) ; sx persisted after additional 15 ' and transferred to ED.  Given albuterol nebulizer, sx resolved.  EKG wnl -  observed for 2 hrs. d/c  to home
8/25/21 pt admitted to hospital after a fall at home where he hit the right side of his face; CT showed acute IPH and SAH; found to be positive for COVID on admission; O2 supplementation; dexamethasone; pt's condition worsened; he refused PEG tube or any advanced measures; condition declined; inpatient hospice care; pt expired in the hospital
Fever of 101.8 F approx 72 hours after vaccination; This is a spontaneous report from a contactable consumer.  A 51-year-old female patient (not-pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported. On 19Jan2021, the patient experienced fever of 101.8 F approximately 72 hours after vaccination.  The patient underwent lab tests and procedures which included SARS-COV-2 test: negative   on 20Jan2021.  The patient outcome of the event was recovered on Jan2021.  The information on the batch number has been requested.
Headache, body ache, joint pain, fatigue and loss of appetite. Symptoms started about 2 hours after waking up. Symptoms ended by the next morning. No medication was taken during the symptoms. Regular vegetarian meals and water intake when able. Slept about 3 hours during the day and rested early night.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug allergies and concomitant medications were not reported. On unspecified dates, the patients were administered ROTATEQ (Lot# L038536, expiration date: 19-AUG-2017, dose, frequency and route were not reported) that were improperly stored at 31.3 Fahrenheit for 124 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Client states she woke up this morning and noted left upper arm to be reddened and swollen. She came to health department to report adverse event. Upon inspection of left upper arm  it was noted to be reddened, warm to touch, swollen and client states area was also itchy. Area measures 2 x 2.5 cm.  Client noted she also just started taking Clindamycin today bid for 10 days for a gum abscess per her PCP.  She was advised to try warm compresses to area and Benadryl topical for itching.
arm hurt soon after shot. at midnight that night burning hands and feet, fever, fatigue, nausea, electricity in my left chest-heart area. This all lasted 5 days long. fever never went over 103. used freeze packs for burning hands and feet. July 26th this year, dizziness, nausea, migraine, electricity in heart, left side body numbness, stabbing pain in back, stiff neck, brain fog, muscle spasms, fatigue. all of the symptoms from july 26 have not subsided yet. I am taking meds, have seen several docs, been to several ERs, several mris, and 2 ct scans. i also am now on an anti inflammatory diet, herbal tea for liver detox, charcoal to detox, neuro massage, chiro adjustments. nothing has made a full recovery. but some things help sometimes. depends on the day. I am almost to week 4
patient received her booster dose of the Pfizer COVID 19 Vaccine; Chills; Fevers; Loss of taste and smell; Loss of taste and smell; This is a spontaneous report from a contactable consumer or other non-health professional. A 26-years-old female patient received bnt162b2 (COMIRNATY Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on unspecified date as Dose Number Unknown (Booster), Single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccination included, patient received COVID-19 Vaccine (Primary Immunization series complete but unknown manufacturer) via an unspecified route of administration on an unspecified date for covid-19 immunization. On 20Oct2021, the patient experienced chills, fevers, loss of taste and smell, on unspecified date, patient received her booster dose of the Pfizer COVID 19 Vaccine. Reported as the patient received her booster dose of the Pfizer COVID 19 Vaccine and she was now having symptoms that represent the "virus." She had chills with fevers and loss of taste and smell. Also stated that this was the "3rd" day of symptoms. Reporter was trying to understood why this would happen with the booster. She understood the "other things, with fevers and chills, but not understood" why the patient would loose taste and smell. The clinical outcome of events was not recovered at the time of this report.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Left arm pain between elbow and wrist, extreme nausea, pounding headache, dizziness, blurry vision, rash on face, extreme fatigue
Patient developed joint pain 2 days S/P vaccines.  No joint swelling, from all jts.  Involves left wrist, left ankle, all fingers, no fever, no rash.
Slight Fever for about 3hrs. Tylenol taken. Vomiting same evening from 11pm until 4am; Nausea and Fatigue for 48hrs after 10am vaccination
lesion on chest; face and eyes swollen; face and eyes swollen; neck and arm swelled up; neck and arm swelled up; rash on arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (lesion on chest), EYE SWELLING (face and eyes swollen), SWELLING FACE (face and eyes swollen), SWELLING (neck and arm swelled up) and PERIPHERAL SWELLING (neck and arm swelled up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (lesion on chest), EYE SWELLING (face and eyes swollen), SWELLING FACE (face and eyes swollen), SWELLING (neck and arm swelled up), PERIPHERAL SWELLING (neck and arm swelled up) and RASH (rash on arm). At the time of the report, CHEST DISCOMFORT (lesion on chest), EYE SWELLING (face and eyes swollen), SWELLING FACE (face and eyes swollen), SWELLING (neck and arm swelled up), PERIPHERAL SWELLING (neck and arm swelled up) and RASH (rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter states that the symptoms manifested 10 days after receiving the vaccine and was advised not to get the second vaccine.   Treatment for the event included methylprednisolone 4 mg (Cadista).
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 4:08 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment information provided.   This case was linked to MOD-2021-402935 (Patient Link).
Patient was vaccinated out of state so lot information is not available to me.  Fully vaccinated person requiring hospitalization with COVID-19.  Patient discharged to HCF on 10/12/2021
A report has been received from a Health Professional concerning a 50 year old, Female subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on 01-Oct-2013. It was reported that a 50 years old woman was vaccinated with FLUMIST on 01-Oct-2013. The outcome of the event of 50 year old woman vaccinated with FLUMIST is unknown. The report was considered to be non-serious.
Patient notes strong reaction to 2nd Pfizer Covid vaccine and wondering how booster should be handled.   Noted 2nd dose of Pfizer vaccine on 4/5/2021.  Patient felt like her body was being crushed from the outside.  Felt particular chest pain, stomach pain.  The stomach pain lasted several weeks.  Took Prilosec for a few weeks.   Initial dose of Pfizer - March 15th, 2021 - no issues, barely knew got shot. Timing following 2nd dose - April 5th, 2021 - no local reactions.   She notes a few hours later, was feeling bad.  Noon shot and 4pm symptoms started. Took extra strength tylenol but waking up every hour, groaning out loud. Felt horrible, chest "killing me" and felt like "elephant on chest".  Notes crushing chest pain and heavy stomach pain (lasted several weeks)  Crushing chest pain (she thought was having heart attack); no issues with heart issues other than HTN in past.  Did not seek treatment.  Next day, "foggy" and "spacy".  The following day, more coherent but then stomach started bothering.  No vomiting, diarrhea, or constipation.  Aware of it all the time.  Not keeping awake. Symptoms would be intermittent with some sharper pains at time.  Endorses GERD in past and increased her Prilosec to 2 per day (did not improve), went back to 1 per day.  Eventually stomach pains resolved on their own.  Took 2-3 weeks to resolve.   Treatments - nothing else provided.
Exacerbated depression symptoms. Cried for 3 days after the second does.
on 8/21/2020, the patient was administered improperly stored VARlVAX; This spontaneous report was received from a nurse, referring to a 4-year-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 21-AUG-2020, the patient was administered improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection (strength, vaccination scheme, anatomical site of injection and route of administration were not reported; lot number T002848, which has been verified to be valid, expiration date reported and validated as 23-JAN-2022) as prophylaxis (product storage error). The vaccine was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot number S008566, which has been verified to be valid, expiration date reported and validated as 16-NOV-2021).  The vaccine underwent multiple temperature excursions between minus 14 degrees Celsius (C) to -10C (-12.1C) for 3 hours and multiple temperature excursions between -9C to 8C (-7.5C) for 8 hours and 30 minutes, as recorded by a data logger. There was no previous temperature excursion.
I felt an itchy feeling and scratched it. When I looked at the sight (where I had the injection) there were small welts, approximately 6 or 7 taking up an oval about 1" x 2".  I applied lotion to prevent further itching. In the morning, the welts were  smaller and the patch is red and still itches. I am continuing  to  apply lotion.
Took the first dose / right before they ran out / you irreponsibly ran out of vaccine; Took the first dose / about maybe 2 years ago / the pandemic hit before i got a chance to get the second; This case was reported by a consumer via call center representative and described the occurrence of product supply issue in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received about maybe 2 years ago from the time of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue and social problem. On an unknown date, the outcome of the product supply issue and social problem were unknown.  Additional details were provided as follows: The patient reported case for herself. The age at vaccination was not applicable for this report. The patient took the first dose of the Shingrix vaccine right before they ran out and the pandemic hit before the patient got a chance to get the second dose, which led to product supply issue and social problem. The patient enquired if the patient should just take one more shot. The patient was advised CDC (Centers for Disease Control and Prevention) provided guidance and was advise to talk to the healthcare provider about this guidance and on the individual situation.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR100456:Same reporter, Duplicate case.
1) Headaches 2) Visual Change: felt like water was in her left eye 3) Neck pain 4) Total body myalgias 5) BP 0f 140/100
jaw was sore; patient went to touch their jaw it made a popping noise.; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (jaw was sore), JOINT NOISE (patient went to touch their jaw it made a popping noise.) and FATIGUE (fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN JAW (jaw was sore), JOINT NOISE (patient went to touch their jaw it made a popping noise.) and FATIGUE (fatigue). At the time of the report, PAIN IN JAW (jaw was sore), JOINT NOISE (patient went to touch their jaw it made a popping noise.) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was not reported. No treatment medication was not reported
Pt vaccinated with Engerix-B on 3/30/90. On 4/19/90, developed angioneurotic edema; treated w/ Benadryl & Solumedrol. Received a 2nd vacc. on 4/30/90 and developed antioneurotic edema on 5/11/90; treated w/Atarax.
This case was reported by a healthcare professional to a sales representative and described the occurrence of injection site reaction in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date in 2006, on or before 03 October 2006, the subject received a dose of Fluarix (site of injection, dose number and lot number not provided). On an unspecified date in 2006, on or before 03 October 2006 less than one year after vaccination with Fluarix, the subject experienced a rash on hands and feet. At the time of initial reporting, 03 October 2006, the event was worse. The healthcare professional considered the event was probably related to vaccination with Fluarix. Follow-up received on 16 April 2007. The nurse reported that the 46-year old female received FLUARIX (intramuscular) on 29 September 2006 in her left arm. No other concurrent medications or vaccinations were received by the subject. Two days later, on 01 October 2006, the subject experienced a 3 inch x 2 and 1/2 inch red area on her left arm that was not painful and tender. She was seen by a physician. On 06 October 2006, the events resolved. The reported considered that the events were related to FLUARIX.
severe joint pain; extremely severe allergic reaction to Typhim Vi; Initial information regarding this unsolicited valid non-serious case received from a patient and transmitted to Sanofi on 25-Nov-2020.  This case involved a 34 year old female patient who experienced severe joint pain (arthralgia) and extremely severe allergic reaction to Typhim Vi (Allergy to vaccine), while she received vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  Relevant medical history, medical treatment, vaccination details and family history were not provided.  At the time of the event, the patient possibly had an ongoing egg allergy.  No concomitant medication was taken by the patient.   On an unknown date in 2019, the patient received a dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE (lot number and expiry date not reported) via intramuscular route in the left arm prophylactic vaccination.  On an unknown date in 2019, the patient had extremely severe allergic reaction to Typhim Vi (Allergy to vaccine), unknown latency following the administration of TYPHOID VI POLYSACCHARIDE VACCINE.   On 26-Dec-2019, the patient developed a non-serious severe joint pain (arthralgia), unknown latency following the administration of TYPHOID VI POLYSACCHARIDE VACCINE.   It was reported that she had not received a flu shot for many years because she felt sick for about a week afterwards.   Relevant laboratory test was not reported.  No corrective treatment was received.  On an unknown date, the event outcome was recovered for arthralgia and unknown for allergy to vaccine.  There would be no information available on batch number for this case.  Additional information regarding this unsolicited valid non-serious case received from a patient and transmitted to Sanofi on 25-Nov-2020.  New event allergy to vaccine was added. Corresponding fields and narrative updated accordingly.
Had some numbness that started about 20 min after the injection that lasted for about 10 min. After about an hour, my arm was swollen and very painful to move and touch. I put an ice pack on and took Tylenol but the pain and swelling didn?t completely subside. I went to bed with Tylenol PM to help me sleep and woke up several times from the pain. Throughout the day today (2nd day), the pain has steadily gotten worse. I can barely move my arm due to the immense pain. The swelling is still there. I have been icing it and taking Tylenol but the pain has only gotten worse. I feel achy in my neck and the pain is radiating down my arm to my forearm, wrist, and fingers.
PATIENT GIVEN VACCINE IN RIGHT THIGH. APPROXIMATELY 10 MINUTES AFTER PARENT NOTED THAT HIVES WERE APPEARING ON RIGHT SIDE OF FACE. IMMEDIATELY GRABBED A NURSE AND PROVIDER SINCE CHILD WAS NOT HAVING ANY DIFFICULTY BREATHING. UPON FURTHER INSPECTION; HIVES WERE NOTED ON LEFT SHOULD AND LEFT THIGH AS WELL. PROVIDER PRESCRIBED BENADRYL TO ASSIST WITH HIVES.
Headache, Myalgia, Arthralgia, Fever, states felt warm,however did not take temperature Narrative: Took two days off of work. Symptoms resolved after 3 days.